Wednesday, 7 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Marksans Pharma Ltd

NSE: MARKSANS · BSE: 524404 · Pharmaceuticals & Biotechnology · 30 announcements

Share price
₹325.00
Market cap
₹14,728 Cr
Revenue (annual)
₹2,951 Cr
Net profit (annual)
₹417.9 Cr
P/E (TTM)
28.5×Sector 47.4×
Promoter holding
43.87%+0.00% QoQ
FII holding
17.47%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

15:11 IST NSE
Credit Rating

Marksans Pharma Credit Rating

India Ratings revised Marksans Pharma's bank loan outlook to Positive from Stable, affirming its IND AA- rating. The upgrade covers facilities worth ₹195.75 Crore.

Value
₹195.8 Cr